🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

FTSE 100 flat while business confidence hits two-year high

Published 31/01/2024, 11:05
© Reuters.  FTSE 100 Live: Stocks flat while business confidence hits two-year high
UK100
-

Proactive Investors -

UK business confidence at two-year high, Lloyds

UK businesses started 2024 with their confidence at the highest level in nearly two years boosted by cooling inflation and hopes for interest rates cuts, according to a survey published on Wednesday.

The Lloyds Bank Business Barometer jumped by nine points to 44% this month, its strongest since February 2022.

Hann-Ju Ho, senior economist Lloyds Bank Commercial Banking (LON:LLOY), said weaker inflation and hopes of interest rate cuts pushed the index to its highest level for the month of January since 2016.

"With ongoing geopolitical issues and a general election on the horizon, businesses will have factored these into their risk radars and will be working to prepare for any potential impacts on their trading prospects," he said.

"Also, half of all companies say they’re planning to increase headcount in the coming year. Despite that and the changes to minimum wage that will come into force in April, expectations for staff pay fell back following last month’s increase."

Companies also scaled back plans for increasing the prices they charge for a second month in a row, the first back-to-back decrease since June 2022, Lloyds said.

GSK targets £3billion sales for RSV vaccine

Sticking with GSK (LON:GSK), boss Emma Walmsley said the company expects its new RSV vaccine to bring in annual sales of “at least £3 billion” in future.

Speaking to journalists after the company released better-than-expected 2023 results, she said: "We’re absolutely delighted with the RSV launch, in four months reaching blockbuster status."

She explained: "We’re only 11% penetration so far in the US. We do expect ‘24 to be a year of good growth as we continue to drive penetration. We’re excited about being able to hopefully add a further cohort of the 50 to 59 year olds."

The RSV vaccine is currently approved for people aged over 60, but GSK is seeking regulatory consent for those aged over 50.

Read more on Proactive Investors UK

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.